hsv 1 and hsv 2
New herpes treatment from common herb
A new anti-herpes agent derived from a common herb effectively treats and prevents the disease in animals. Researchers from Dalhousie University in Nova Scotia present their data today at the 103rd General Meeting of the American Society for Microbiology.
Major Herpes Vaccine Trial Launched in Women
A pivotal efficacy trial of an experimental vaccine designed to prevent genital herpes in women began enrolling volunteers this week. The study will determine the vaccine’s ability to prevent genital herpes disease in women who are free of two common types of herpes simplex viruses (HSV): HSV-1 and HSV-2. The trial will eventually enroll 7,550 women in at least 16 sites in the United States.